Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Immune regulatory gene polymorphisms as predisposing risk factors for the development of factor VIII inhibitors in Indian severe haemophilia A patients.

Pinto P, Ghosh K, Shetty S.

Haemophilia. 2012 Sep;18(5):794-7. doi: 10.1111/j.1365-2516.2012.02845.x. Epub 2012 May 28.

PMID:
22630053
2.

Polymorphisms in genes involved in autoimmune disease and the risk of FVIII inhibitor development in Italian patients with haemophilia A.

Bafunno V, Santacroce R, Chetta M, D'Andrea G, Pisanelli D, Sessa F, Trotta T, Tagariello G, Peyvandi F, Margaglione M.

Haemophilia. 2010 May;16(3):469-73. doi: 10.1111/j.1365-2516.2009.02150.x. Epub 2009 Dec 14.

PMID:
20015215
3.

Analysis of cytokine genes polymorphism as markers for inhibitor development in haemophilia A.

Chaves D, Belisário A, Castro G, Santoro M, Rodrigues C.

Int J Immunogenet. 2010 Apr;37(2):79-82. doi: 10.1111/j.1744-313X.2009.00893.x. Epub 2010 Jan 14.

PMID:
20082647
4.

Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A.

Astermark J, Oldenburg J, Pavlova A, Berntorp E, Lefvert AK; MIBS Study Group.

Blood. 2006 Apr 15;107(8):3167-72. Epub 2005 Dec 27.

5.

Impact of polymorphisms in genes involved in autoimmune disease on inhibitor development in Chinese patients with haemophilia A.

Lu Y, Ding Q, Dai J, Wang H, Wang X.

Thromb Haemost. 2012 Jan;107(1):30-6. doi: 10.1160/TH11-06-0425. Epub 2011 Nov 24.

PMID:
22116520
6.

Immune system polymorphisms and factor VIII inhibitor formation in Brazilian haemophilia A severe patients.

Agostini D, Rosset C, Botton MR, Kappel DB, Vieira IA, Gorziza RP, Salzano FM, Bandinelli E.

Haemophilia. 2012 Nov;18(6):e416-8. doi: 10.1111/hae.12015. Epub 2012 Sep 13. No abstract available.

PMID:
22970761
7.

Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A.

Astermark J, Oldenburg J, Carlson J, Pavlova A, Kavakli K, Berntorp E, Lefvert AK.

Blood. 2006 Dec 1;108(12):3739-45. Epub 2006 Aug 22.

8.

Genetic variants of TNFα, IL10, IL1β, CTLA4 and TGFβ1 modulate the indices of alcohol-induced liver injury in East Indian population.

Roy N, Mukhopadhyay I, Das K, Pandit P, Majumder PP, Santra A, Datta S, Banerjee S, Chowdhury A.

Gene. 2012 Nov 1;509(1):178-88. doi: 10.1016/j.gene.2012.07.077. Epub 2012 Aug 10.

PMID:
22902304
9.

[Relationship between factor VIII inhibitor development and polymorphisms of TNFα and CTLA-4 gene in Chinese Han patients with hemophilia A].

Zhang LL, Yu ZQ, Zhang W, Cao LJ, Su J, Bai X, Ruan CG.

Zhonghua Xue Ye Xue Za Zhi. 2011 Mar;32(3):168-72. Chinese.

PMID:
21535954
10.

Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.

Gouw SC, Van Der Bom JG, Van Den Berg HM, Zewald RA, Ploos Van Amstel JK, Mauser-Bunschoten EP.

Haemophilia. 2011 Mar;17(2):275-81. doi: 10.1111/j.1365-2516.2010.02420.x. Epub 2010 Nov 11.

PMID:
21070499
11.

New associations: INFG and TGFB1 genes and the inhibitor development in severe haemophilia A.

de Alencar JB, Macedo LC, de Barros MF, Rodrigues C, Shinzato AH, Pelissari CB, Machado J, Sell AM, Visentainer JE.

Haemophilia. 2015 Jul;21(4):e312-6. doi: 10.1111/hae.12685. Epub 2015 Apr 30.

PMID:
25930091
12.

Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients.

Lochan A, Macaulay S, Chen WC, Mahlangu JN, Krause A.

Haemophilia. 2014 Sep;20(5):687-92. doi: 10.1111/hae.12436. Epub 2014 Jun 21.

PMID:
24953131
13.

F8 and F9 mutations in US haemophilia patients: correlation with history of inhibitor and race/ethnicity.

Miller CH, Benson J, Ellingsen D, Driggers J, Payne A, Kelly FM, Soucie JM, Craig Hooper W; Hemophilia Inhibitor Research Study Investigators.

Haemophilia. 2012 May;18(3):375-82. doi: 10.1111/j.1365-2516.2011.02700.x. Epub 2011 Nov 21.

PMID:
22103590
14.

Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies.

Coppola A, Santoro C, Tagliaferri A, Franchini M, DI Minno G.

Haemophilia. 2010 Jan;16 Suppl 1:13-9. doi: 10.1111/j.1365-2516.2009.02175.x. Review.

PMID:
20059564
15.

Interleukin-1beta and -10 polymorphisms influence erosive reflux esophagitis and gastritis in Taiwanese patients.

Cheng HH, Chang CS, Wang HJ, Wang WC.

J Gastroenterol Hepatol. 2010 Aug;25(8):1443-51. doi: 10.1111/j.1440-1746.2010.06310.x.

PMID:
20659236
16.

A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A.

Lozier JN, Rosenberg PS, Goedert JJ, Menashe I.

Haemophilia. 2011 Jul;17(4):641-9. doi: 10.1111/j.1365-2516.2010.02473.x. Epub 2011 Mar 1.

17.

Genetic risk factors for inhibitors to factors VIII and IX.

Oldenburg J, Pavlova A.

Haemophilia. 2006 Dec;12 Suppl 6:15-22. Review.

PMID:
17123389
18.

The correlation between gene mutations and inhibitor development in patients with haemophilia A in southern Iran.

Haghpanah S, Sahraiian M, Afrasiabi A, Enayati S, Peyvandi F, Karimi M.

Haemophilia. 2011 Sep;17(5):820-1. doi: 10.1111/j.1365-2516.2011.02510.x. Epub 2011 Mar 4. No abstract available.

PMID:
21371201
19.

Inhibitor development and management in three non-severe haemophilia A patients with T295A variant.

Ivaskevicius V, Goldmann G, Horneff S, Marquardt N, Klein C, Albert T, Zeitler H, Oldenburg J.

Hamostaseologie. 2014;34 Suppl 1:S9-12. doi: 10.5482/HAMO-14-02-0013.

PMID:
25382774
20.

Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls.

Pavlova A, Diaz-Lacava A, Zeitler H, Satoguina J, Niemann B, Krause M, Scharrer I, Hoerauf A, Wienker T, Oldenburg J.

Haemophilia. 2008 Mar;14(2):355-60. Epub 2007 Dec 10.

PMID:
18081831

Supplemental Content

Support Center